Consumption of an omega-3 fatty acids product, INCELL AAFATM, reduced side-effects of CPT-11 (irinotecan) in mice

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 983-988

  Hardman, W E ^a   Moyer, M P ^b   Cameron, I L ^c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b INCELL Corporation LLC ^*  (United States)

^c University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Cancer chemotherapy; CPT 11; Omega 3 fatty acids

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; DRUG VEHICLE; ICOSAPENTAENOIC ACID; INCELL AAFA; IRINOTECAN; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTHENIA; CONTROLLED STUDY; DIETARY INTAKE; INTESTINE CRYPT; LEUKOCYTE COUNT; LEUKOPENIA; LIVER DISEASE; LIVER HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; DINOPROSTONE; DUODENUM; FATTY ACIDS, OMEGA-3; LIVER; MALE; MEMBRANE LIPIDS; MICE; ORGAN SIZE;

EID: 0037128672     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600175     Document Type: Article

References (35)

1. Effect of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas
2. Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer
3. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer
4. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2, release in healthy subjects
5. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B Study 9473
6. Cell proliferation, differentiation, and apoptosis are modified by n-3 polyunsaturated fatty acids in normal colonic mucosa
7. Liver
8. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites?
9. Effects of dietary fatty acid composition on tumor growth and metastasis
10. Modification of membrane composition, eicosanoid metabolism, and immunoresponsiveness by dietary omega-3 and omega-6 fatty acid cources, modulators of ultraviolet-carcinogenesis
11. Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity
12. 3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet
13. Fish oil supplementation enhanced CPT-11 (Irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side effects
14. Efficacy of treatment of colon, lung and breast human carcinoma xenografts with: Doxorubicin, cisplatin, irinotecan or topotecan
15. Dietary fish oil sensitizes A549 lung xenografts to doxorubicin chemotherapy
16. Three % w/w fish oil concentrate increased the efficacy of doxorubicin against MDA-MB 231 human breast cancer xenografts and reduced the side effects to the host mouse
17. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ilieum and cecum
18. Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia
19. 2 and water absorbtion of large intestine in rats
20. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women
21. Camptosar
22. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice
23. Irinotecan (CPT-11): A brief overview
24. Efficacy and toxicity of irinotecan in patients with colorectal cancer
25. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
26. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
27. − secretion induced by the antitumor drug, irinotecan (CPT-11), in the rat colon
28. − secretion in isolated rat colon
29. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1
30. Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: Increased therapeutic effects and decreased toxicity of cyclophosphamide
31. The current status of camptothecin analogues as antitumor agents
32. Protection from chemotherapy-indiced alopecia by docosahexaenoic acid
33. Mechanism of lipid mobilization associated with cancer cachexia: Interaction between polyunsaturated fatty acid, eicosapentaenoic acid and inhibitory guanine nucleotide-regulatory protein
34. Frequency of micronuclei in the peripheral blood and bone marrow of cancer-prone mice chronically exposed to 2450 MHz radiofrequency radiation
35. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (2nd edn.)